HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A case of advanced esophageal cancer with multiple lymph node metastases successfully treated with induction chemotherapy consisting of nedaplatin and 5-FU followed by chemoradiotherapy].

Abstract
A 61-year-old male patient had esophageal carcinoma with multiple mediastinal and right supraclavicular lymph node metastases. Chemotherapy consisting of infusion of nedaplatin and continuous infusion of 5-fluorouracil was performed. After three courses of the chemotherapy, the patient was treated with a combination of cisplatin and 5-FU and radiotherapy. However, only radiotherapy was performed after 18 Gy because of grade 3 leukocytonenia during the chemoradiotherapy. The patient achieved a partial response (nearly complete response) for 9 months after the initiation of the treatment. In conclusion, chemotherapy with NDP and 5-FU followed by chemoradiotherapy is effective and safe for patients with esophageal carcinoma with multiple lymph node metastases.
AuthorsTomonari Sasaki, Katsumasa Nakamura, Takashi Toba, Masahiko Kimura, Saijo Ohga, Yusuke Urashima, Hiromi Terashima, Kouji Masuda
JournalGan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 29 Issue 8 Pg. 1417-20 (Aug 2002) ISSN: 0385-0684 [Print] Japan
PMID12214470 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Organoplatinum Compounds
  • nedaplatin
  • Fluorouracil
Topics
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Carcinoma, Squamous Cell (drug therapy, radiotherapy, secondary)
  • Drug Administration Schedule
  • Esophageal Neoplasms (drug therapy, pathology, radiotherapy)
  • Fluorouracil (administration & dosage)
  • Humans
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Organoplatinum Compounds (administration & dosage)
  • Remission Induction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: